Clinical Trial

The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation

Study acronym: INS1GHT
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim for this clinical trial is to evaluate if colchicine in addition to standard of care improves insulin sensitivity in individuals with type 1 diabetes, systemic low-grade inflammaiton and reduced insulin sensitivity. The insulin sensitivity will be evaluated by a hyperinsulinemic, euglycemic clamp.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-20.
Status change: Not Yet Recruiting → Recruiting 2025-12-22
Trial Details
NCT Number NCT07247734
Lead Sponsor Asger Lund, MD
Collaborators: University of Copenhagen
Conditions Type 1 Diabetes, Chronic Inflammation, Insulin Sensitivity
Enrollment 26 participants
Start Date 2025-12-01
Primary Completion 2026-12-22 (estimated)
Study Completion 2027-06-22 (estimated)
Updated on ClinicalTrials.gov 2025-12-23